高级搜索
郭鑫, 杜华, 师迎旭. 外泌体传递非编码RNA调控乳腺癌耐药[J]. 肿瘤防治研究, 2022, 49(10): 1071-1076. DOI: 10.3971/j.issn.1000-8578.2022.22.0142
引用本文: 郭鑫, 杜华, 师迎旭. 外泌体传递非编码RNA调控乳腺癌耐药[J]. 肿瘤防治研究, 2022, 49(10): 1071-1076. DOI: 10.3971/j.issn.1000-8578.2022.22.0142
GUO Xin, DU Hua, SHI Yingxu. Exosomal Delivery of Non-coding RNA Regulates Breast Bancer Drug Resistance[J]. Cancer Research on Prevention and Treatment, 2022, 49(10): 1071-1076. DOI: 10.3971/j.issn.1000-8578.2022.22.0142
Citation: GUO Xin, DU Hua, SHI Yingxu. Exosomal Delivery of Non-coding RNA Regulates Breast Bancer Drug Resistance[J]. Cancer Research on Prevention and Treatment, 2022, 49(10): 1071-1076. DOI: 10.3971/j.issn.1000-8578.2022.22.0142

外泌体传递非编码RNA调控乳腺癌耐药

Exosomal Delivery of Non-coding RNA Regulates Breast Bancer Drug Resistance

  • 摘要: 耐药性是乳腺癌治疗的重大挑战之一。有多种原因和机制导致乳腺癌耐药的发生。外泌体及其内容物(DNA、mRNA、蛋白质、非编码RNA等)是细胞间通讯的重要介质,在肿瘤进展、转移、复发中发挥作用。其中,外泌体携带的非编码RNA在限制药物疗效方面起着至关重要的作用。本文对国内外关于外泌体非编码RNA与乳腺癌耐药相关的最新研究进展作一综述。

     

    Abstract: Drug resistance is a major challenge in the treatment of breast cancer. Many causes and mechanisms lead to the occurrence of drug resistance in breast cancer. Exosomes and their contents (DNA, mRNA, protein, and non-coding RNA) are important mediators of intercellular communication and play a role in tumor progression, metastasis, and recurrence. Among them, non-coding RNA carried by exosomes plays a crucial role in limiting drug efficacy. This article reviews the latest research progress on the relationship between exosomal non-coding RNA and drug resistance of breast cancer at home and abroad.

     

/

返回文章
返回